Recombinant liposomal factor VIIa (Recoly)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant liposomal factor VIIa (Recoly)
Drug Alias NameLongSeven重组凝血因子VIIa的脂质体 - RecolyNecLip-rFVIIa
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor IX stimulantsCoagulation factor X stimulantsBlood coagulation pathway activation +[4] 
TargetsCoagulation factor IXCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRecoly Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecoly Nv
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A